More articles about NYSE:NVS | Wall St. Cheat Sheet

April 24, 2013

Novartis Earnings: Here’s Why the Stock is Down Now

Here's your Cheat Sheet to earnings...

April 01, 2013

Dell’s Buyout Dilemma and Slow U.S. Manufacturing Growth: Market Recap

After briefly touching positive territory early in the morning, the U.S. equity markets struggled with losses all day to end in the red across the board...

April 01, 2013

4 Healthcare Stock Stories for Monday Investment Wellness

Analysis of Top healthcare Business News: 4 Healthcare Stock Stories for Monday Investment Wellness

April 01, 2013

Will Novartis’s India Setback Bother These Top Institutional Shareholders?

Novartis AG's Top Institutional Shareholders for Q1 2013.

April 01, 2013

Analysts: CBS to Gain From Sports Ratings and 4 New Opinions Investors Must Take Note Of

Here's what analysts had to say about these companies today...

April 01, 2013

Will This Court Decision Be a Thorn in the Side of Novartis?

On Monday, India’s supreme court denied the Basel, Switzerland-based pharmaceutical manufacturer’s request for patent protection of its Glivec cancer treatment...

March 22, 2013

Will This Treatment Help Anacor’s Stock Soar?

Shares of Anacor Pharmaceuticals received a boost Friday after reporting positive trial results for a medicine designed to treat eczema...

March 21, 2013

Should You Consider Johnson & Johnson In Your Portfolio?

Johnson & Johnson is well-positioned to profit from a sector that is coming to the center stage. The stock is trading at all-time highs from support by the markets on its excellent earnings and revenue growth rates. How long can this continue?